Effect of two forms of alendronate administration upon bone mass after two years of treatment

Journal of Clinical Densitometry

Volumn 5, Issue 1, 2002, Pages 27-34

  Sosa, M ^a   Hernandez D ^a   Segarra, M C ^a   Gomez A ^a   De La Pena E ^a   Betancor, P ^a  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

Author keywords

Alendronate; Biochemical markers bone remodeling; Bone mineral density; Densitometry; Fractures; Osteoporosis; Withdrawals

Indexed keywords

ALENDRONIC ACID;

ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; BONE REMODELING; DRUG EFFECT; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL;

EID: 0036215983     PISSN: 10946950     EISSN: None     Source Type: Journal    
DOI: 10.1385/JCD:5:1:027     Document Type: Article

References (22)

1. Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling
2. Alendronate increases bone density and bone strength at the distal radius in postmenopausal women
3. Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study
4. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
5. Prevention of nonvertebral fractures by alendronate
6. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
7. Esophagitis associated with the use of alendronate
8. Prevalencia de la obesidad en España
9. Definición y epidemiología de la menopausia
10. Precise measurement of the vertebral mineral content using computed tomography
11. Quantitative computed tomography: Update 1987
12. Dual energy radiography versus quantitative computer tomography for the diagnosis of osteoporosis
13. Metodologia de la evaluación de la masa ósea
14. The range of bone mineral density in healthy canarian women by dual x-ray absorptiometry radiography and quantitative computer tomography
15. A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis
16. Calculating confidence intervals for relative risks (odds ratios) and standarised ratios and rates
17. Involutional osteoporosis
18. Osteoporosis. Current techniques and recent developments in quantitative bone densitometry
19. Bisphosphonates: Pharmacology and use in the treatment of tumor-induced hypercalcaemic and metastatic bone disease
20. Clinical pharmacology of alendronate disodium
21. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis